Yehuda Reznick - 06 Jun 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Yehuda Reznick
Issuer symbol
ORMP
Transactions as of
06 Jun 2024
Net transactions value
$0
Form type
4
Filing time
10 Jun 2024, 17:15:29 UTC
Previous filing
18 Apr 2024
Next filing
09 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +760 +2.6% 30,560 06 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of 760 Restricted Stock Units ("RSUs") that will vest in two equal installments on October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.